Optimizing Management of Low Back Pain Through the Pain and Disability Drivers Management Model

NCT03949179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2020-03-24

No results posted yet for this study

Summary

This study aims to determine the feasibility of conducting a future randomized controlled trial to collect preliminary data on the effectiveness of a previously validated approach that takes into account all the pain and disability vectors associated with low back pain - the Pain and Disability Drivers Management Model (PDDM).

The overall objective is to provide data to assess the feasibility of implementing a future randomized clinical trial to evaluate the impact of the PDDM on the management of non-specific LBP in a clinical setting and to explore the short-term effect of using the model on patient's clinical outcomes.

Conditions

  • Mechanical Low Back Pain

Interventions

DEVICE

The Low Back Pain and Disability Drivers Management (PDDM) model

The Low Back Pain and Disability Drivers Management (PDDM) model aims to identify the domains influencing pain and disability to guide clinical decisions. The model is composed of five domains upon which the clinician can base his assessment and orientate treatment allocation and includes: 1) nociceptive pain drivers (i.e., somatic, inflammatory or mixed pain), 2) nervous system dysfunction (NSD) drivers (i.e., sensitization of the peripheral and/or central nervous system), 3) comorbidity drivers (i.e., physical and/or mental health comorbidities), 4) cognitive-emotional drivers (i.e., maladaptive cognitions and/or behaviors) and 5) contextual drivers (i.e., occupational-related and social environmental contextual drivers). This profiling will inform and lead the clinician's treatment approach based on the combined contribution of each domain driving the experience of pain and disability.

Sponsors & Collaborators

  • Quebec Pain Research Network

    collaborator OTHER
  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Yannick Tousignant-Laflamme, PhD · School of Rehabilitation, University of Sherbrooke

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-03
Primary Completion
2019-12-15
Completion
2019-12-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03949179 on ClinicalTrials.gov